Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus salivarius UCC118 and Reduced Prevalence of Gestational Diabetes Mellitus

Research synthesisModerate evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across all 4 studies, 4 reported beneficial effects of Lactobacillus salivarius UCC118 on reducing gestational diabetes mellitus (GDM) prevalence, with a predominant effect size of moderate. Statistically significant findings were observed in 2 out of 4 studies (both meta-analyses), reporting risk reductions of 48% (RR 0.52, P=0.003) and 29% (RR 0.71, P=0.03). All studies examined pregnant women, but none specified a dose of the specific strain.

  • Studied populations: pregnant women

Caveats: All studies reviewed probiotics broadly rather than specifically isolating Lactobacillus salivarius UCC118, making it unclear whether effects are attributable to this particular strain. The two largest analyses included multiple probiotic formulations, and no study reported the dose of UCC118 specifically. The lowest-quality study (evidence score 1) was a narrative review and contributed no independent data.

Generated May 10, 2026
4 of 4 papers
Back to top